COX5B and neoplasm: In multivariate analysis, the COX5B level (p = 0.004), gender (p = 0.023), age (p = 0.011), height (p = 0.023), tumor differentiation status (p = 0.005), adjuvant chemotherapy received (p = 0.011), and OCR T/N ratio (p < 0.001) remained as potential predictors of DFS.